A new study reveals that the presence of certain bacteria in the gut may play a significant role in influencing an individual’s response to a commonly prescribed class of antidepressants. Researchers found that patients with higher levels of specific microbial strains showed more pronounced improvements in symptoms compared to those with lower levels. The findings suggest a potential link between gut health and mental health treatment efficacy, offering fresh insights into personalized medicine approaches. The study highlights how microbial composition could impact therapeutic outcomes for conditions like depression.